Granules India Ltd.

GRANULES

₹563.1

2.21% (12.2)

Market Cap

₹13,656 Cr.

P/E

33.69

About

Granules India Limited, a vertically integrated pharmaceutical manufacturing company based in Hyderabad, India, specializes in producing APIs, PFIs, and FDs. Known for its product-focused business mod… Read more

Granules India Limited, a vertically integrated pharmaceutical manufacturing company based in … Read more

Low

288

52W Range

High

567

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE

Latest

12.57%

3yr Average

15.58%

5yr Average

18.04%

Net Profit Margin

Latest

8.99%

3yr Average

10.47%

5yr Average

12.26%

ROCE

Latest

19.2%

3yr Average

21.17%

5yr Average

22.1%

Debt to Equity

Latest

0.38

3yr Average

0.39

5yr Average

0.41

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operational Metrics

US DMF Filings (.)
Source
Europe DMF Filings (.)
Source
Manufacturing Capacity - Metformin (MTPA)
Source
Manufacturing Capacity - Ibuprofen (MTPA)
Source
Total reactor capacity (kL)
Source
Manufacturing Capacity - Paracetamol (MTPA)
Source
Number of ANDA's Approved By USFDA (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Filed (.)
Source
Number of ANDA's Approved (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Suppliers

IOL Chemicals And Pharmaceuticals Ltd.

FAQs on Granules India Ltd. Business

What does Granules India do?

Granules India Limited is a high-growth pharmaceutical company in India, specializing in APIs, PFIs, and FDs. It holds a leadership position in generic drugs like Paracetamol and Ibuprofen.

Who are the competitors of Granules India?

Granules India major competitors are Solara Active Pharma, IOL Chem & Pharma, Neuland Laboratories, Glenmark Life Scienc, Shilpa Medicare, Aarti Pharmalabs, AMI Organics.
Market Cap of Granules India is ₹13,656 Crs.
While the median market cap of its peers are ₹5,479 Crs.

Is Granules India financially stable compared to its peers?

Granules India seems to be less financially stable compared to its peers.
Altman Z score of Granules India is 5.83 and is ranked 5 out of its 8 competitors.

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Jun			Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec